AbCellera Biologics(us:ABCL)
2.91
+2.11%
Updated on 2024-12-23
Open:2.82
Close:2.91
High:2.95
Low:2.82
Pre Close:2.85
Volume:1.82M
Amount:5.27M
Turnover:0.62%
Shares:294.67M
MarketCap:857.48M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 168 | 113762788 | 38.61% | 18 | 39 | 71 |
| 2024-03-31 | 166 | 119936236 | 40.85% | 28 | 47 | 56 |
| 2023-12-31 | 161 | 118968483 | 40.91% | 26 | 44 | 59 |
| 2023-09-30 | 186 | 119035473 | 41.08% | 19 | 37 | 88 |
| 2023-06-30 | 211 | 122556209 | 42.38% | 37 | 43 | 94 |
| 2023-03-31 | 211 | 127664998 | 44.26% | 21 | 60 | 90 |
| 2022-12-31 | 217 | 127350087 | 44.40% | 33 | 79 | 76 |
| 2022-09-30 | 197 | 120688285 | 42.23% | 43 | 71 | 52 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Baker Bros. Advisors Lp | 27525640 | 9.37% | 4615887 | 20.15% |
| 2024-03-31 | Baillie Gifford & Co | 23180089 | 7.89% | -864707 | -3.60% |
| 2024-03-31 | Voya Investment Management Llc | 10632134 | 3.62% | 7949 | 0.07% |
| 2024-03-31 | Capital World Investors | 8351293 | 2.84% | 0 | |
| 2024-03-31 | Credit Suisse Ag/ | 4547315 | 1.55% | -30935 | -0.68% |
| 2024-03-31 | Orbimed Advisors Llc | 4180768 | 1.42% | 0 | |
| 2024-03-31 | Arrowmark Colorado Holdings Llc | 4105095 | 1.40% | 0 | |
| 2024-03-31 | Blackrock Inc. | 3900564 | 1.33% | -5149 | -0.13% |
| 2024-03-31 | Founders Fund Vii Management, Llc | 3773530 | 1.29% | 0 | |
| 2024-03-31 | Federated Hermes, Inc. | 2815459 | 0.96% | -302221 | -9.69% |
About
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Address:2215 Yukon Street
Website:http://www.abcellera.com
Market Movers